Abstract
Influenza virus causes annual epidemics and occasional pandemics. Frequent mutations in circulating influenza strains (“antigenic drift”) result in the need for annual vaccination. More than two-thirds of persons in the U.S. are recommended for annual vaccination. Because influenza vaccine is available seasonally, mass vaccination strategies are well suited to its delivery. Although doctors offices are the most frequent setting for influenza vaccination overall, workplaces, clinics, and community sites (retail stores and pharmacies) also are common vaccination settings. Influenza vaccination also is delivered in mass vaccination clinics to health care workers and military personnel. Universal influenza vaccination, which has been recommended as a strategy to improve prevention by increasing vaccination coverage and providing indirect protection of adults by decreasing infection and transmission among children, would require expanded use of mass vaccination, for example in schools, as well as in the community. Influenza pandemics occur when a new influenza A subtype is introduced into the population (“antigenic shift”). Most or all of the population is susceptible to the pandemic virus and two doses of vaccine may be needed for protection. U.S. pandemic preparedness and response plans indicate that the entire population should be vaccinated beginning with defined priority groups including those who provide essential services including healthcare and those at highest risk of severe illness and death. Pandemic influenza vaccination will occur primarily through the public sector in mass clinic settings. Vaccination program planning must consider issues including coordination, staffing, clinic location and lay-out, security, record keeping, and communications. Exercising vaccination clinics is important for preparedness and can be done in the context of annual influenza vaccination.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Belshe RB, Newman FK, Cannon J, et al. (2004) Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351:2286–2294
Bridges CB, Thompson WW, Meltzer MI, et al. (2000) Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000 284:1655–1663
Broder KR, MacNeil A, Malone S (2005) Who’s calling the shots? Pediatricians’ adherence to the 2001–2003 Pneumococcal Conjugate Vaccine Shortage Recommendations. Pediatrics (in press)
CDC (1968) Recommendations of the Public Health Service Advisory Committee on Immunization Practices: A2 influenza virus vaccine, monovalent, 1968–69. MMWR 17:368
CDC (1968a) Recommendations of the Public Health Service Advisory Committee on Immunization Practices: influenza vaccines — 1968–69. MMWR 17:246–247
CDC (2000) Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation: a report of the National Vaccine Advisory Committee. MMWR 49(RR-01)1–13
CDC (2004a) Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices. MMWR 53(RR-06):1–40
CDC (2004b) Estimated influenza vaccination coverage among adults and children — United States, September 1–November 30, 2004
CDC (2004c) Maxi-Vac 1.0 http://www.bt.cdc.gov/agent/smallpox/vaccination/maxivac/index.asp (accessed 12/17/2004)
D’Heilly SJ, Nichol KL (2004) Work site-based influenza vaccination in healthcare and non-healthcare settings. Infect Control Hosp Epidemiol 25:941–945
Earhart KC, Beadle C, Miller LK, et al. (2001) Outbreak of influenza in a highly vaccinated crew of U.S. navy ship. Emerg Infect Dis 7:463–465
Gaglani MJ, Piedra PA, Herschler GB, et al. (2004) Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000–2001 influenza A (H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med 158:65–73
Glenn GM, Kenney RT, Hammond SA, Ellingsworth LR (2003) Transcutaneous immunization and immunostimulant strategies. ImmunolAllergy Clin N Am 23:787–813
Glezen PW (2004) Control of influenza. Tex Heart Inst J 31:39–41
Grabenstein JD, Guess HA, Hartzema AG (2001) People vaccinated by pharmacists: descriptive epidemiology. J Am Pharm Assoc 41:46–52
Gray GC, Callahan JD, Hawksworth AW, Fisher CA, Gaydos JC (1999) Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis 5:379–385
Hehme N. Engelmann H. Kunzel W. Neumeier E. Sanger R (2002) Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines. Med Microbiol Immunol 191:203–208
Hupert N, Cuomo J (2003) Bioterrorism and Epidemic Outbreak Response Model (BERM). DHHS Agency for Healthcare Research and Quality (AHRQ). Available at http://www.ahrq.gov/news/press/pr2003/btmodpr.htm (accessed 12/17/2004)
Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM (2004) Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 351:2295–2301
McArthur MA, Simor AE, Campbell B, McGeer A (1999) Influenza vaccination in long-term-care facilities: structuring programs for success. Infect Control Hosp Epidemiol 20:499–503
Monto AS, Davenport FM, Napier JA, Francis T Jr. (1969) Effect of vaccination of a school-age population upon the course of an A2/Hong Kong influenza epidemic. Bull World Health Org 41:537–542
National Foundation for Infectious Diseases (2003) Increasing influenza immunization rates in infants and children: putting recommendations into practice. http://www.nfid.org/publications/pediatricflu.pdf (accessed 2/7/05)
Neustadt RE, Feinberg HV (1978) The Swine Flu Affair: Decision-Making on a Slippery Slope. Government Printing Office, Washington DC pp 1–189
Neuzil KM, Hohlbein C, Zhu Y (2002) Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism, and secondary illness in families. Arch Pediatr Adolesc Med 156:986–991
Nichol KL, Lind A, Margolis KL, et al. (1995) The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 333:889–893
Parry MF, Grant B, Iton A, Parry PD, Baranowsky D (2004) Influenza vaccination: a collaborative effort to improve the health of the community. Infect Control Hosp Epidemiol 25:929–932
Principi N, Esposito S, Gasparini R, Marchisio P, Crovari P (2004) Burden of influenza in healthy children and their households. Arch Dis Child 89:1002–1007
Richert TA, Sugaya N, Fesdon DS, Glezen PW, Simonsen L, Tashiro M (2001) The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344:889–896
Salgado CD, Giannetta ET, Hayden FG, Farr BM (2004) Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol 25:923–928
Sartor C, Tissot-Dupont H, Zandotti C, Martin F, Roques P, Drancourt M (2004) Use of a mobile cart influenza program for vaccination of hospital employees. Infect Control Hosp Epidemiol 25:918–922
Szilagyi PG, Iwane MK, Humiston, et al. (2003b) Time spent by primary care practices on pediatric influenza vaccination visits: implications for universal influenza vaccination. Arch Pediatr Adolesc Med 157:191–195
Szilagyi PG, Iwane MK, Schaffer S, et al. (2003a) Potential burden of universal influenza vaccination of young children on visits to primary care practices. Pediatrics 112:821–828
Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K (2004) Influenza-associated hospitalizations in the United States. JAMA 292:1333–1340
Thompson WW, Shay DK, Weintraub L, Cox N, Alderson LJ, Fukuda K (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179–186
US Department of Health and Human Services (2005) http://www.hhs.gov/nvpo/pan demicplan/ (accessed 2/7/05)
Weycker D, Edelsberg J, Halloran ME, et al. (2005) Population-wide benefits of routine vaccination of children against influenza. Vaccine (in press)
influenza/en/ (accessed 2/7/05)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schwartz, B., Wortley, P. (2006). Mass Vaccination for Annual and Pandemic Influenza. In: Plotkin, S.A. (eds) Mass Vaccination: Global Aspects — Progress and Obstacles. Current Topics in Microbiology and Immunology, vol 304. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-36583-4_8
Download citation
DOI: https://doi.org/10.1007/3-540-36583-4_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-29382-8
Online ISBN: 978-3-540-36583-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)